rs386833903
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004646.4(NPHS1):c.2156_2163delTGCACTGC(p.Leu719ProfsTer4) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,610,010 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004646.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- congenital nephrotic syndrome, Finnish typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NPHS1 | NM_004646.4 | c.2156_2163delTGCACTGC | p.Leu719ProfsTer4 | frameshift_variant | Exon 16 of 29 | ENST00000378910.10 | NP_004637.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPHS1 | ENST00000378910.10 | c.2156_2163delTGCACTGC | p.Leu719ProfsTer4 | frameshift_variant | Exon 16 of 29 | 1 | NM_004646.4 | ENSP00000368190.4 | ||
| NPHS1 | ENST00000585400.1 | n.338_345delTGCACTGC | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | |||||
| NPHS1 | ENST00000353632.6 | c.2156_2163delTGCACTGC | p.Leu719ProfsTer4 | frameshift_variant | Exon 16 of 28 | 5 | ENSP00000343634.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152268Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1457742Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 725376 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74396 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Pathogenic:4
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000056463 / PMID: 15780077). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56463). This premature translational stop signal has been observed in individual(s) with NPHS1-related conditions (PMID: 15780077, 27882743). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This sequence change creates a premature translational stop signal (p.Leu719Profs*4) in the NPHS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS1 are known to be pathogenic (PMID: 11317351, 11854170, 12039988). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at